Lindsey Steglich
Medical · Susanville, CANPI 1538573365
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,712 of the $21,640 with a category attached, or 72.6%. 33 manufacturers reported payments, led by Organon at 54.4% of the total. Reporting peaked in 2021 at $11,104 and has fallen 88.5% since, to $1,279 in 2025. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $74.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$12K
- Merck$5K
- AbbVie$950
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$817
- Novo Nordisk$813
- Daiichi Sankyo Inc.$418
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$15,71273%
- Travel & lodging$7463%
- Food & beverage$5,18324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 21 | $11,773 |
| Merck | 18 | $4,920 |
| AbbVie | 53 | $950 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 56 | $817 |
| Novo Nordisk | 30 | $813 |
| Daiichi Sankyo Inc. | 23 | $418 |
| Bayer | 8 | $233 |
| Pfizer | 10 | $208 |
| Lilly USA, LLC | 7 | $194 |
| AstraZeneca | 5 | $179 |
| Idorsia Pharmaceuticals US Inc | 5 | $158 |
| Exact Sciences | 9 | $137 |
| Axsome Therapeutics, Inc. | 6 | $120 |
| Amgen | 6 | $95 |
| Dexcom, Inc. | 4 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Johnson & Johnson | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
| Gilead | 2 | $41 |
| Theratechnologies Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Kyowa Kirin, Inc. | 2 | $32 |
| Optinose US, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Vertex | 1 | $22 |
| GSK | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Alk-abello, Inc | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,640 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $608 |
| Gabapentin | 15 | $148 |
| Hydroxyzine Hcl | 12 | $146 |
| Amlodipine Besylate | 19 | $135 |
| Lisinopril | 26 | $127 |
| Doxycycline Hyclate | 18 | $117 |
| Fluticasone Propionate | 17 | $115 |
| Losartan Potassium | 17 | $98 |
| Atorvastatin Calcium | 17 | $98 |
| Prednisone | 33 | $88 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $52 |
| Tizanidine Hcl | 11 | $33 |
| Cephalexin | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other medical in Susanville
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.